EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER


SENDUR M. A. , AKSOY S., UNCU D., Demir H., YUKSEL S., EKINCI A. S. , et al.

39th ESMO Congress (ESMO), Madrid, İspanya, 26 - 30 Eylül 2014, cilt.25